Copernicus Capital Management LLC
Copernicus Capital Management LLC latest Q4_2020 13F filings reported $6,416,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is -93.89%. This fund has 15 securities concentrations of 100% weights.
Copernicus Capital Management LLC largest holding is BioMarin Pharmaceutical Inc. with weight of 14.65% and $940,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
|FILE DATE||REPORT PERIOD||QTR YEAR||FILE TYPE||NOS. OF STOCKS||REPORTED VALUE||RETURN|